Penumbra, Inc. to Attend Major Healthcare Conference
Penumbra, Inc. (NYSE: PEN) is set to showcase its dedication to advancing healthcare technology at the Piper Sandler 36th Annual Healthcare Conference this December. The management team is excited to discuss their innovative approaches and the latest developments in their pioneering thrombectomy solutions. This significant event provides an excellent opportunity to engage with industry peers and share insights into pressing medical challenges.
Event Details
At the conference, Penumbra will present vital information about their groundbreaking technologies, designed to address some of the most challenging medical conditions faced by patients today. The presentation is scheduled to occur at:
Event: Piper Sandler 36th Annual Healthcare Conference
Date: Wednesday, December 4, 2024
Time: 8:00 AM ET / 5:00 AM PT
Innovations in Thrombectomy
Penumbra has consistently been at the forefront of catheter-based thrombectomy technologies. Their state-of-the-art devices aim to significantly improve patient outcomes in severe cases of ischemic stroke, venous thromboembolism, and acute limb ischemia. Through the innovation of computer-assisted vacuum thrombectomy (CAVT), Penumbra's solutions enable healthcare providers to work more effectively in critical situations, ensuring quick and safe removal of blood clots.
Supporting Healthcare Providers Worldwide
With a presence in over 100 countries, Penumbra's mission is to enhance the lives of patients and support medical professionals with advanced tools and technologies. Their commitment extends beyond simply treating conditions; they aim to elevate the quality of life for patients undergoing treatment.
Accessing the Presentation
For those interested, a live webcast of the presentation will be available. You can find it in the "Events and Presentations" section under the "Investors" tab on the company's website. The webcast is anticipated to remain accessible for at least two weeks post-event, allowing ample opportunity for investors and stakeholders to catch up on the insights shared.
About Penumbra, Inc.
Penumbra, Inc. has established itself as a leader in the thrombectomy space. Their commitment to innovation manifests in a broad portfolio of tools that treat blood clots from head to toe. By focusing on removing obstacles to effective patient care, they have become a trusted partner for healthcare providers worldwide.
Investor Relations
For more information about Penumbra, Inc. and its revolutionary approaches in healthcare, you can reach their investor relations team through their website. They are dedicated to keeping stakeholders informed of all major developments and upcoming events.
Frequently Asked Questions
What event will Penumbra, Inc. be attending?
Penumbra, Inc. will attend the Piper Sandler 36th Annual Healthcare Conference on December 4, 2024.
What time will the presentation take place?
The presentation is scheduled for 8:00 AM ET / 5:00 AM PT.
How can I access the webcast?
The webcast can be accessed under the "Events and Presentations" section on Penumbra's website and will be available for at least two weeks after the conference.
What technologies does Penumbra focus on?
Penumbra specializes in innovative thrombectomy technologies to treat conditions like ischemic stroke and venous thromboembolism.
Where can I find more information about Penumbra?
For more detailed information about their technologies and mission, visit the official Penumbra website.
